Evogene (EVGN) CDO buys stock, holds 40,000 options
Rhea-AI Filing Summary
Evogene Ltd. (EVGN) reported that Chief Development Officer Tarcic Gabi purchased 1,129 Ordinary Shares on June 4, 2026 at $0.60 per share in an open-market or private transaction. Following this buy, Tarcic holds 1,129 Ordinary Shares directly and has stock options covering 40,000 Ordinary Shares at an exercise price of $2.305 per share, expiring November 20, 2034. The option position was unchanged and is disclosed for informational purposes, with vesting over four years from the November 20, 2024 grant date.
Positive
- None.
Negative
- None.
Insider Trade Summary
Net Buyer: 1,129 shares
Net Buy
2 txns
Insider
Tarcic Gabi
Role
Chief Development Officer
Bought
1,129 shs ($677.40)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Purchase | Ordinary Shares | 1,129 | $0.60 | $677.40 |
| holding | Stock Option (right to buy) F1, F2 | -- | -- | -- |
Holdings After Transaction:
Ordinary Shares — 1,129 shares (Direct);
Stock Option (right to buy) — 40,000 shares (Direct)
Footnotes (2)
- F1. The options reported in this row vest over a period of four years, with 25% vesting upon the first anniversary of the November 20, 2024 grant date, and the remainder vesting on an equal quarterly basis (6.25% per quarter) over the following twelve quarters, such that all options will be fully vested on the four-year anniversary of the November 20, 2024 grant date.
- F2. There were no transactions in the securities reported in this row, and the Reporting Person's holdings in these securities is being provided for informational purposes only.
Key Figures
Ordinary Shares purchased: 1,129 shares
Purchase price per Ordinary Share: $0.60 per share
Ordinary Shares held after transaction: 1,129 shares
+5 more
8 metrics
Ordinary Shares purchased
1,129 shares
Purchase on 2026-06-04 by Chief Development Officer Tarcic Gabi
Purchase price per Ordinary Share
$0.60 per share
Open-market or private transaction on 2026-06-04
Ordinary Shares held after transaction
1,129 shares
Direct ownership following 2026-06-04 purchase
Underlying shares for stock options
40,000 Ordinary Shares
Stock Option (right to buy) position held directly
Stock option exercise price
$2.305 per share
Exercise price for Stock Option (right to buy) on Ordinary Shares
Stock option expiration date
2034-11-20
Expiration of Stock Option (right to buy) over 40,000 Ordinary Shares
Initial option vesting
25%
Vests on first anniversary of November 20, 2024 grant date
Ongoing quarterly vesting rate
6.25% per quarter
Over twelve quarters after first anniversary of grant date
Key Terms
Stock Option (right to buy), Ordinary Shares, exercise price, vesting
4 terms
Stock Option (right to buy) financial
"Stock Option (right to buy) position with underlying Ordinary Shares"
exercise price financial
"conversion_or_exercise_price: 2.3050 per share for stock options"
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
vesting financial
"options reported in this row vest over a period of four years"
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
FAQ
What insider transaction did EVGN report for Tarcic Gabi on June 4, 2026?
Evogene reported that Chief Development Officer Tarcic Gabi purchased 1,129 Ordinary Shares on June 4, 2026 at $0.60 per share, in a transaction classified as a purchase in an open market or private transaction.
Did the June 4, 2026 EVGN Form 4 involve any stock option exercises?
No. The filing states that for the stock option holdings, there were no transactions and that the reporting person’s option holdings are provided for informational purposes only.
How do Tarcic Gabi’s EVGN options vest?
The options vest over four years: 25% on the first anniversary of the November 20, 2024 grant date, and the remaining 75% vest in equal quarterly installments of 6.25% over the following twelve quarters.
AI-generated analysis. How Rhea-AI works. Not financial advice.
